What? When? Why?
Latest Happenings in Business World
22
Nov-2019
Noteworthy aspects in the Digestive Enzyme Supplements Market
Digestive Enzyme Supplements Market Analysis By Origin (Animal, Plant, Microbial), By Application (Additional Supplements, Medical & Infant Nutrition, Sports Nutrition) And By Region
Introduction:
Digestive enzyme supplements
A digestive enzyme is a complex protein produced by your body to help break down food into smaller molecules so that your body can absorb them. Most digestive enzymes are produced by the pancreas, although some are provided by the mouth, stomach and small intestine.
Examples of digestive enzymes include:
• Amylase: separates complex sugars into smaller molecules such as maltose
• Lipase: breaks down complex fats into lower fatty acids and glycerol
• Pepsin: breaks down proteins in foods such as meat, eggs and dairy products into smaller peptides.
• Lactase: breaks down the sugar of milk called lactose.
• Cholecystokinin: a secreted hormone in the small intestine that causes gallbladder contraction and the release of bile, as well as the release of digestive enzymes by the pancreas.
• Trypsin: breaks down protein to become an amino acid
Supplements are digestive enzymes in the form of a pill or chewable tablet. Some are sold with probiotics. They can be easily purchased online. These supplements were initially designed for people with pancreatic insufficiency, a condition in which the pancreas fail to produce enough enzymes for digestion.
Common side effects
Constipation, nausea, cramps, and diarrhea are the most common side effects of digestive enzyme supplements. As with all over-the-counter dietary supplements, digestive enzyme supplements are not controlled by the US Food and Drug Administration. Although manufacturers are required to ensure that their product is at least safe, there is no established control over the consistency of the essay or any mandatory stringent safety testing.
Benefits:
The labels of digestive enzyme supplements often include general claims that say
• Promote healthy digestion
• Optimize the distribution of fats, carbohydrates and proteins
• Promotes optimal absorption of nutrients
• Reduce gas, bloating, indigestion and constipation after meals
• Helps your body assimilate foods that are difficult to digest
• Support colon health
IBS is usually diagnosed based on symptoms and eliminating other conditions. At present, the cause of IBS is not known. The treatment, therefore, aims to relieve symptoms, such as:
• Diarrhea
• Constipation
• Swelling
• Gas
Because digestive enzymes help with food breakdown, supplements can help relieve common symptoms of IBS.
Market Trends:
The segment of animal origin has conquered the largest market share in the global digestive enzymes market.
The animal sub-segment represents the largest share of the original segment and will follow the same trend over the forecast period. The main factors responsible for segment growth include the efficacy of the animal-derived enzymes in various diseases or conditions, such as pancreatitis, exocrine pancreatic insufficiency and pancreatic cancer. However, ethical issues with animal products in some consumers are expected to hamper segment growth. In addition, allergies and consumer sensitivity to these animal products should also hinder the growth of their market.
In contrast, the microbial enzyme is expected to experience the fastest growth rate over the forecast period. This growth rate of microbial products can be attributed to factors such as low production cost and high enzymatic activity.
Regional Analysis:
North America has captured most of the market and must maintain its dominant position
North America has become the largest regional market in terms of revenue. The increasing prevalence of chronic gastrointestinal diseases, the rapid aging of the population, the growing demand for preventive medications and the presence of the leading market players are the main factors contributing to the size of the market. In addition to the high prevalence of gastrointestinal disorders, changes in lifestyle, poor eating habits and high disposable income contribute to healthy growth. On the other hand, Asia Pacific should record the fastest growth rate.
Key Findings:
• Plant-based enzymes accounted for 41.3% of total revenues in 2015 and are expected to provide significant growth, as these products help reduce acid indigestion, heartburn, reflux and other conditions like digestion disorders. Also, the ease of use of these products in a wide pH range is likely to extend their application.
• Europe is expected to experience a substantial increase in revenue of 7.3% between 2016 and 2025. Easy availability of products due to the presence of a large number of supermarket chains and greater awareness of the problems. Gastrointestinal should feed the market size. the next nine years
• Central and South America should expect substantial growth due to the increasing prevalence of digestive disorders in the region. Increased consumer awareness of the damage of the digestive system due to the lack of supplements and nutrients in the human body should promote expansion.
• The industry is very competitive due to the presence of several manufacturers, large and small. The key players seek to increase market share and profitability through product innovation and strengthening their R&D activities. Companies are raising their expenses for the establishment of strategic partnerships with distribution companies.
• In November 2015, Vox Nutrition launched a new private brand digestive enzyme supplement, Digestion Enzyme Pro Blend. The product aims to improve the absorption of nutrition, help the body break down delicate proteins, promote healthy digestion and relieve common reactions of food intolerance
WRITTEN BY:
CATEGORY
RECENT POST
CLIENTS
.webp)
